MENU
+Compare
ITOS
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$7.46
Change
+$0.30 (+4.20%)
Capitalization
284.93M

ITOS iTeos Therapeutics Forecast, Technical & Fundamental Analysis

ITeos Therapeutics Inc is a biopharmaceutical company... Show more

ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ITOS with price predictions
Apr 23, 2025

ITOS in upward trend: price rose above 50-day moving average on April 22, 2025

ITOS moved above its 50-day moving average on April 22, 2025 date and that indicates a change from a downward trend to an upward trend. In of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 15, 2025. You may want to consider a long position or call options on ITOS as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ITOS just turned positive on April 15, 2025. Looking at past instances where ITOS's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ITOS advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ITOS moved out of overbought territory on April 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ITOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ITOS broke above its upper Bollinger Band on April 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ITOS entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ITOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.483) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (8.628) is also within normal values, averaging (252.992).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ITOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ITOS is expected to report earnings to fall 7.92% to -93 cents per share on May 08

iTeos Therapeutics ITOS Stock Earnings Reports
Q1'25
Est.
$-0.93
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.86
Q1'24
Missed
by $0.09
The last earnings report on March 05 showed earnings per share of -100 cents, beating the estimate of -104 cents. With 264.31K shares outstanding, the current market capitalization sits at 284.93M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of biopharmaceuticals therapeutic products and services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSBAX57.80N/A
N/A
Nuveen Dividend Growth A
RSQAX22.50N/A
N/A
Russell Inv Equity Income A
GLOSX18.83N/A
N/A
Victory Pioneer Global Equity A
JMCGX19.88N/A
N/A
Jacob Discovery Fd Inv
FZABX26.99N/A
N/A
Fidelity Advisor Diversified Intl Z

ITOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
-4.03%
BMRN - ITOS
43%
Loosely correlated
+0.72%
IBO - ITOS
41%
Loosely correlated
+0.34%
RCUS - ITOS
40%
Loosely correlated
+0.25%
NVAX - ITOS
40%
Loosely correlated
+19.52%
IMNM - ITOS
39%
Loosely correlated
+3.54%
More